Nanobiotechnology company founded in 2016 by Elon Musk and Max Hodak developing brain-machine interface to connect humans and computers based in San Francisco, California. Neuralink develops devices aimed to help people with brain diseases and injuries, with a long term vision of developing devices that merge humans with AI.

All edits by  Phil Mohun 

Edits on 30 Sep, 2020
Phil Mohun"Fixed inconsistent spelling of company name after 2016 incorporation"
Phil Mohun edited on 30 Sep, 2020
Edits made to:
Article (+9/-9 characters)

NeurolinkNeuralink’s 2019 non-peer reviewed whitepaper demonstrates two of their devices System A and System B implanted in rats which took electrophysiological recordings as they moved around freely. Digitized broadband signals were processed in real-time to identify action potentials, also referred to as spikes, using an online detection algorithm. Neuralink uses custom spike-detection software for filter out false positive spikes. Their threshold was set to >0.35 Hz to quantify the number of electrodes recording spiking units. The simultaneous recording from over 3000 inserted electrodes in a freely moving rat was reported. The placement of electrodes was successful 87% of the time in 19 rats. Neuralink did not demonstrate capabilities for modulating neural activity, but state that their device is designed to be capable of electrical stimulation on every channel.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.